Strong First Quarter Financials
Reported adjusted EPS of $2.35 and $10.2 billion of premium revenue for Q1 2026; consolidated medical cost ratio (MCR) of 91.1% and adjusted pretax margin of 1.6% for the quarter.
Reaffirmed Full-Year Guidance
Reaffirmed full-year 2026 guidance of approximately $42 billion in premium revenue and at least $5.00 in adjusted EPS.
Improving Medical Trend vs. 2025
Management expects 5% medical cost trend for 2026 versus a reported 7.5% trend in 2025 that included ~250 basis points of acuity shift; Q1 results were modestly favorable to expectations and annualized Q1 trend would be slightly better than the 5% assumption.
Medicare Duals & Integrated Product Progress
Medicare Q1 MCR was 89.8%; transition of MMP members to new integrated FIDE/HIDE products completed successfully and performance so far exceeded initial expectations (noted as an early positive for duals strategy).
Marketplace Membership Quality and Margin Focus
Marketplace membership at 305,000 (slightly above prior guidance) with 70% renewals and a concentrated silver-tier book (approx. 50% silver), supporting greater stability and predictability; Q1 Marketplace MCR 84% (adjusted to ~79.5% excluding prior-year impacts).
Solid Cash Flow and Parent Liquidity Plan
Operating cash flow of $1.1 billion in Q1 and $35 million in subsidiary dividends harvested; parent cash balance ~$213 million in Q1 with management guidance that parent cash could exceed ~$600 million by year-end based on expected dividends.
Large New Contract Win (Florida Kids) and Embedded Earnings
Florida CMS (Florida Kids) implementation underway with an estimated $6 billion run-rate program; embedded earnings cited as a driver of future value (management referenced ~$2.50 of embedded earnings and noted implementation costs this year that will contribute positively in 2027).
Balance Sheet and Reserve Position
Debt was 6.1x trailing 12-month EBITDA and debt-to-cap ~48%; management described capital foundation as strong, with continued reserve strength and confidence in actuarial processes.